Benchmark Holdings (GB:BMK) has released an update.
Benchmark Holdings PLC, an aquaculture biotech firm, reported a dip in Q3 FY24 revenues by 10% year-on-year, attributing the decline to soft shrimp markets and restructuring in their Health segment, despite a solid performance in Genetics and Advanced Nutrition. The company’s streamlining efforts led to a 15% rise in adjusted EBITDA, excluding fair value movement of biological assets. Despite market headwinds, the company maintains a positive outlook, underlining actions taken to ensure profitability and long-term shareholder value.
For further insights into GB:BMK stock, check out TipRanks’ Stock Analysis page.
